A large family from Argentina with Prekallikrein deficiency due to a compound heterozygosis (T insertion in intron 7 and Asp558Glu in exon 15): Prekallikrein Cordoba

American Journal of Hematology

Volumn 85, Issue 5, 2010, Pages 363-366

  Girolami, Antonio ^a   Marun, Sebastian ^b   Vettore, Silvia ^a   Scaliter, Gilda ^b   Molina, Angelica ^b   Scarparo, Pamela ^a   Tabares, Aldo ^b   Lombardi, Anna Maria ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b Centro Médico de Córdoba S A   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; COUMARIN; ENOXAPARIN; HIGH MOLECULAR WEIGHT KININOGEN; LOW MOLECULAR WEIGHT HEPARIN; PREKALLIKREIN; WARFARIN;

ADULT; ANAMNESIS; ARGENTINA; ARTICLE; CASE REPORT; COMPRESSION GARMENT; DEEP VEIN THROMBOSIS; ELECTROPHORETIC MOBILITY; EXON; FEMALE; GENE MUTATION; HEART INFARCTION; HUMAN; INTRON; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTHROMBIN TIME;

ADULT; ARGENTINA; EXONS; FEMALE; HETEROZYGOTE; HUMANS; INTRONS; MALE; MUTAGENESIS, INSERTIONAL; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREKALLIKREIN; VENOUS THROMBOSIS;

EID: 77951553409     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21654     Document Type: Article

References (30)

1. Chung DW, Fujikawa K, McMullen BA, Davie EW. Human plasma prekallikrein, a zymogen to a serine protease that contains four tandem repeats. Biochemistry 1986;25:2410-2417.
2. Colman RW. Contact Activation (Kallikrein-Kinin) pathway: Involving inflammatory, fibrinolytic, anticoagulant physiologic and pathophisiologic activities. In: Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ, editors. Hemostasis and Thrombosis, 5th ed. Philadelphia: Lippincot & Williams; 2006. pp 107-130.
3. Hathaway WE, Belhasen LP, Hathaway HS. Evidence for a new plasma thromboplastin factor I. Case report, coagulation studies and physicochemical properties. Blood. 1965;26:521-532.
4. Goodnough LT, Saito H, Ratnoff DD. Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: A report of 21 patients and a review of 50 previously reported cases. Medicine (Baltimore) 1983;62:248-255
5. Entes K, La Duca FM, Tourbaf KD. Fletcher factor deficiency, source of variations of the actived partial thromboplastin time test. Am J Clin Pathol 1981;75:626-628.
6. DeLa Cadena RA. Fletcher factor deficiency in a 9-year-old girl: Mechanisms of the contact pathway of blood coagulation. Am J Hematol 1995;48:273-277.
7. Saito H, Kojima T. Factor XII, Prekallikrein and high molecolar weight kininogen. In: High KA, Roberts HR, editors. Molecular Basis of Thrombosis and Haemostasis. New York: M. Dekker Inc.; 1995. pp 269-285.
8. Wuillemin WA, Furlan M, von Felten A, Lammie B. Functional characterization of a variant prekallikrein (PK Zurich). Thromb Haemost 1993;70:427-432.
9. Bouma BN, Kerbiriou DM, Baker J, Griffin JH. Characterization of a variant prekallikrein, prekallikrein Long Beach, from a family with mixed cross-reacting material-positive and cross-reacting material-negative prekallikrein deficiency. J Clin Invest 1986;78:170-176.
10. De Stefano V, Leone G, Teofili L, et al. Association of Graves' disease and prekallikrein congenital deficiency in a patient belonging to the first CRM+ prekallikrein-deficient Italian family. Thromb Res 1990;60:397-1340
11. Kyrle PA, Niessner H, Deutsch E, et al. CRM1 severe Fletcher factor deficiency associated with Graves' disease. Haemostasis 1984;14:302-306.
12. Lombardi AM, Sartori MT, Cabrio L, et al. Severe prekallikrein (Fletcher factor) deficiency due to a compound heterozygosis (383 Trp stop codon and Cys529Tyr). Thromb Haemost 2003;90:1040-1045.
13. Shigekiyo T, Fujino O, Kanagawa Y, Matsumoto T. Prekallikrein (PK) Tokushima: PK deficiency caused by a Gly401-->Glu mutation. J Thromb Haemost 2003;1:1314-1316.
14. Jones DW, Russel G, Allford SL, et al. Severe prekallikrein deficiency associated with homozygosity for an Arg 94 Stop nonsense mutation. Brit J Haematol 2004;127:220-223.
15. Katsuda I, Maruyama F, Ezaki K, et al. A new type of plasma prekallikrein deficiency associated with homozygosity for Gly104Arg and Asn124Ser in apple domain 2 of the heavy-chain region. Eur J Haematol 2007;79:59-68.
16. François D, Trigui N, Leterreux G, et al. Severe prekallikrein deficiencies due to homozygous C529Y mutations. Blood Coagul Fibrinolysis 2007;18:283-286.
17. Nagaya S, Morishita E, Maruyama K, et al. An elderly case of congenital Prekallikrein deficiency. Nippon Ron Igak Zasshi 2009;46:148-151.
18. Girolami A, Molaro G, Lazzarin M, et al. A "new" congenital haemorrhagic condition due to the presence of an abnormal factor X (factor X Friuli): Study of a large kindred. Br J Haematol 1970;19:179-192.
19. Girolami A, Patrassi GM, De Marco L, Cappellato G. Lack of factor XII antigen in factor XII deficiency as de terminate by electroimmuno assay. Blut 1982;45:141-142.
20. Girolami A, Sticchi A, Bareggi G. Crossover electrophoresis (electrosyneresis) visualization of the abnormal factor X (factor X Friuli). J Lab Clin Med 1972;80:740-747.
21. Yu H, Anderson PJ, Freedman BI, et al. Genomic structure of the human plasma prekallikrein gene, identification of allelic variants, and analysis in end-stage renal disease. Genomics 2000;69:225-234.
22. McMullen BA, Fujikawa K, Davie EW. Location of the disulfide bonds in human plasma prekallikrein: The presence of four novel apple domains in the amino-terminal point of the molecule. Biochemistry 1991;30:2050-2056.
23. Asmis LM, Sulrer I, Furlan M, Lammle B. Prekallikrein deficiency: The characteristic normalizazion of the severely prolunged aPTT following incrased preincubation time is due to autoactivation of factor XII. Thromb Res 2002;105:463-470.
24. Saito H, Goodenough LT, Soria J, et al. Heterogeneity of humanprekallikrein deficiency (Fletcher Factor): Evidence that five of 18 cases are positive for cross-reactive material. New Eng J Med 1981;305:910-914.
25. Currimbhoy Z, Vinciguerra V, Palakavongs P, et al. Fletcher factor deficiency and myocardial infarction. Am J Clin Pathol 1976;65:970-973.
26. Harris MG, Exner T, Rickard KA, Kronenberg H. Multiple cerebral thrombosis in Fletcher factor (prekallikrein) deficiency: A case report. Am J Hematol 1985;19:387-393.
27. Chamary JV, Parmley JL, Hurst LD. Hearing silence: Non-neutral evolution at synonymous sites in mammals. Nat Rev Genet 2006;7:98-108.
28. Narendra U, Gayle JT, Pauer GJT, Hagstrom SA. Genetic analysis of complement factor H related 5, CFHR5, in patients with age-related macular degeneration. Mol Vis 2009;15:731-736.
29. Siddiq A, Lepretre F, Hercberg S, et al. A synonymous coding polymorphism in the alpha2-Heremans-schmid glycoprotein gene is associated with type 2 diabetes in French Caucasians. Diabetes 2005;54:2477-2481.
30. Nielsen KB, Sorensen S, Cartegni L, et al. Seemingly neutral polymorphic variants may confer immunità to splicing-inactivating mutations: A synonymous SNP in Exon 5 of MCAD protects from Deleterious Mutations in a flanking exonic Splicing Enhancer. Am J Hum Gen 2007;80:416-432.